Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 10

    1.

    Diagnosis and prevention of chronic kidney allograft loss.

    Nankivell BJ, Kuypers DR.

    Lancet. 2011 Oct 15;378(9800):1428-37. Review.

    PMID:
    22000139
    [PubMed - indexed for MEDLINE]
    2.

    Benefits of lowering cholesterol in chronic kidney disease.

    de Tena JG, Abejón L, Bernal D, Aguila E, Rodríguez-Zapata M.

    Lancet. 2011 Oct 15;378(9800):1376; author reply 1377-8. No abstract available.

    PMID:
    22000131
    [PubMed - indexed for MEDLINE]
    3.

    Benefits of lowering cholesterol in chronic kidney disease.

    Al-Rasadi K, Banerjee Y.

    Lancet. 2011 Oct 15;378(9800):1376-7; author reply 1377-8. No abstract available.

    PMID:
    22000130
    [PubMed - indexed for MEDLINE]
    4.

    Benefits of lowering cholesterol in chronic kidney disease.

    Mascitelli L, Goldstein MR.

    Lancet. 2011 Oct 15;378(9800):1376; author reply 1377-8. No abstract available.

    PMID:
    22000129
    [PubMed - indexed for MEDLINE]
    5.

    Benefits of lowering cholesterol in chronic kidney disease.

    Lui P.

    Lancet. 2011 Oct 15;378(9800):1375; author reply 1377-8. No abstract available.

    PMID:
    22000127
    [PubMed - indexed for MEDLINE]
    6.

    Chronic kidney disease.

    Levey AS, Coresh J.

    Lancet. 2012 Jan 14;379(9811):165-80. Epub 2011 Aug 15. Review.

    PMID:
    21840587
    [PubMed - indexed for MEDLINE]
    7.

    SHARP: a stab in the right direction in chronic kidney disease.

    Stevens KK, Jardine AG.

    Lancet. 2011 Jun 25;377(9784):2153-4. Epub 2011 Jun 12. No abstract available.

    PMID:
    21663950
    [PubMed - indexed for MEDLINE]
    8.

    The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial.

    Baigent C, Landray MJ, Reith C, Emberson J, Wheeler DC, Tomson C, Wanner C, Krane V, Cass A, Craig J, Neal B, Jiang L, Hooi LS, Levin A, Agodoa L, Gaziano M, Kasiske B, Walker R, Massy ZA, Feldt-Rasmussen B, Krairittichai U, Ophascharoensuk V, Fellström B, Holdaas H, Tesar V, Wiecek A, Grobbee D, de Zeeuw D, Grönhagen-Riska C, Dasgupta T, Lewis D, Herrington W, Mafham M, Majoni W, Wallendszus K, Grimm R, Pedersen T, Tobert J, Armitage J, Baxter A, Bray C, Chen Y, Chen Z, Hill M, Knott C, Parish S, Simpson D, Sleight P, Young A, Collins R; SHARP Investigators.

    Lancet. 2011 Jun 25;377(9784):2181-92. Epub 2011 Jun 12.

    PMID:
    21663949
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    9.

    China's organ transplant system in transition.

    Alcorn T.

    Lancet. 2011 Jun 4;377(9781):1905-6. No abstract available.

    PMID:
    21648120
    [PubMed - indexed for MEDLINE]
    10.

    Everolimus-based, calcineurin-inhibitor-free regimen in recipients of de-novo kidney transplants: an open-label, randomised, controlled trial.

    Budde K, Becker T, Arns W, Sommerer C, Reinke P, Eisenberger U, Kramer S, Fischer W, Gschaidmeier H, Pietruck F; ZEUS Study Investigators.

    Lancet. 2011 Mar 5;377(9768):837-47. Epub 2011 Feb 19. Erratum in: Lancet. 2011 Jun 11;377(9782):2006. Wüthrich, Rudolf P [added].

    PMID:
    21334736
    [PubMed - indexed for MEDLINE]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk